Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
The costs of heart disease in the United States will triple between now and 2030 to more than $800 billion a year, a report commissioned by the American Heart Association predicted Monday.
Treating high blood pressure will be the most expensive part of the cost, rising to $389 billion by 2030, the report projects, with overall heart disease rising by 10 percent by then.
A new study finds that one in five heart defibrillators may be implanted for questionable reasons without solid evidence the devices will help.
The implants shock the heart back into a normal rhythm when it starts beating irregularly. They can prevent sudden death in people with advanced heart failure. But researchers haven’t found a benefit for other patients. Get the full story »
Drug-coated heart stents, such as the Xience model made by Abbott Labs, are as safe as the old bare metal variety for patients with narrowed large coronary arteries, a large European study showed, alleviating concerns about their long-term use.
There was no increase in the number of deaths or heart attacks two years after the drug-coated stent was implanted, according to data presented at the scientific sessions of the American Heart Association in Chicago. Get the full story »
Chicago may have lost out on the heart-stopping NBA talent of Lebron James but may be getting the next best thing Cleveland can offer to repair damaged aortas and clogged cardiac arteries.
In a move likely to shake up the market for heart care in the Chicago area, the well-known Cleveland Clinic’s cardiac surgery program said Thursday that it has signed an affiliation agreement with Central DuPage Hospital in the western Chicago suburbs. Get the full story »
